Additional file 1: Supplemental Figure S1. Vaccine roll-out scenarios. Supplemental Figure S2. Impact of vaccination on hospitalization days. Supplemental Table S1. Impact of confirmed COVID-19 and vaccination on hospitalization, by age groups. Supplemental Figure S3. Impact of vaccination on hospitalization days by age. Supplemental Figure S4. Simulated infection rates. Simulated infection rates under the assumption that no one is vaccinated based on aggregate data from October 1st, 2020 to October 30th, 2021 for the age groups specified in the analysis. We control for age group, vaccine share within age groups and infection-rates in the preceding week, as well as calendar-week fixed effects
Simulations from January 1, 2020 until December 31, 2021 performed with the model that has been cali...
Additional file 1: Appendix 1. Scoring for pro- and against-vaccination reasons. Appendix 2. Structu...
In 2021–2022, influenza vaccine coverage in the US dropped below pre-COVID-19 pandemic levels. Cocir...
Additional file 1: S1 Fig. Effects of full vaccination on the (A) case growth rate, (B) number of IC...
Figure S3. Relative Vaccine Efficacies of Goldblatt et al. PCV13 in a Simulated Trial. Relative vacc...
Figure S2. Simulated Trial of Goldblatt et al. PCV13 in a 3 + 1 Vaccinated Population. Vaccine trial...
Additional file 1: Table S1. Highly predisposing comorbidities or medical therapies. Table S2. Moder...
Additional file 1: Table S1. Characteristics of participants with breakthrough infections, post-vacc...
Additional file 1: Supplementary Figure 1. Directed acyclic graph (DAG) on hypothesis 2: Higher reac...
Developing accurate and reliable methods to estimate vaccine protection is a key goal in immunology ...
Additional file 1: Figure A1. Vaccine effectiveness against referral to hospital, according to age. ...
Heterogeneity between sites in the OR of admission with a positive influenza result. (PDF 33 kb
Objective: To estimate population health outcomes with delayed second dose versus standard schedule ...
This study analyzes the relations between doses administrated of vaccines for Coronavirus disease-20...
Additional file 1: S1. Model Structure. S1.1. Modelling transmission. S1.2. Fitting to the basic rep...
Simulations from January 1, 2020 until December 31, 2021 performed with the model that has been cali...
Additional file 1: Appendix 1. Scoring for pro- and against-vaccination reasons. Appendix 2. Structu...
In 2021–2022, influenza vaccine coverage in the US dropped below pre-COVID-19 pandemic levels. Cocir...
Additional file 1: S1 Fig. Effects of full vaccination on the (A) case growth rate, (B) number of IC...
Figure S3. Relative Vaccine Efficacies of Goldblatt et al. PCV13 in a Simulated Trial. Relative vacc...
Figure S2. Simulated Trial of Goldblatt et al. PCV13 in a 3 + 1 Vaccinated Population. Vaccine trial...
Additional file 1: Table S1. Highly predisposing comorbidities or medical therapies. Table S2. Moder...
Additional file 1: Table S1. Characteristics of participants with breakthrough infections, post-vacc...
Additional file 1: Supplementary Figure 1. Directed acyclic graph (DAG) on hypothesis 2: Higher reac...
Developing accurate and reliable methods to estimate vaccine protection is a key goal in immunology ...
Additional file 1: Figure A1. Vaccine effectiveness against referral to hospital, according to age. ...
Heterogeneity between sites in the OR of admission with a positive influenza result. (PDF 33 kb
Objective: To estimate population health outcomes with delayed second dose versus standard schedule ...
This study analyzes the relations between doses administrated of vaccines for Coronavirus disease-20...
Additional file 1: S1. Model Structure. S1.1. Modelling transmission. S1.2. Fitting to the basic rep...
Simulations from January 1, 2020 until December 31, 2021 performed with the model that has been cali...
Additional file 1: Appendix 1. Scoring for pro- and against-vaccination reasons. Appendix 2. Structu...
In 2021–2022, influenza vaccine coverage in the US dropped below pre-COVID-19 pandemic levels. Cocir...